Key result
Short-chain aliphatic monocarboxylates inhibited L-lactate and pyruvate transport into guinea-pig cardiac myocytes and rat erythrocytes, with the heart cell carrier exhibiting approximately 10-fold higher affinity.
The study provides evidence for two distinct monocarboxylate carriers in heart cells and erythrocytes, with the heart cell carrier showing higher affinity for ketone bodies and acetate, which are important cardiac fuels.
Answers are grounded in this paper and cite their sources.
Monocarboxylate analogs inhibit cardiac lactate transport more potently than erythrocytes; leaves open selective MCT targeting pending human studies.
A range of short-chain aliphatic monocarboxylates, both unsubstituted and substituted with hydroxy, chloro and keto groups, were shown to inhibit transport of L-lactate and pyruvate into both guinea-pig cardiac myocytes and rat erythrocytes. The carrier of heart cells exhibited a higher affinity (approx. 10-fold) for most of the monocarboxylates than did the erythrocyte carrier. A notable exception was L-lactate, whose Km for both carriers was similar. The K1 values of the two carriers for inhibitors such as phenylpyruvate and alpha-cyanocinnamate derivatives were also different. The high affinity of the heart cell carrier for ketone bodies and acetate may be physiologically important, since these substrates are used as fuels by the heart.
No takes yet. Share an insight, caveat, or question.
Poole et al. (1990) studied this question. Short-chain aliphatic monocarboxylates was evaluated on Inhibition of transport of L-lactate and pyruvate. Short-chain aliphatic monocarboxylates inhibited L-lactate and pyruvate transport into guinea-pig cardiac myocytes and rat erythrocytes, with the heart cell carrier exhibiting approximately 10-fold higher affinity.
Synapse has enriched 10 related papers. Consider them for comparative context: